Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $3.5 million.

  • Accendra Health's Treasury Shares rose 7480.16% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 7480.16%. This contributed to the annual value of $2.0 million for FY2024, which is 75.57% down from last year.
  • Per Accendra Health's latest filing, its Treasury Shares stood at $3.5 million for Q3 2025, which was up 7480.16% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Treasury Shares ranged from a high of $4.3 million in Q4 2021 and a low of $2.0 million during Q4 2024
  • In the last 5 years, Accendra Health's Treasury Shares had a median value of $2.7 million in 2022 and averaged $2.9 million.
  • Per our database at Business Quant, Accendra Health's Treasury Shares crashed by 3579.19% in 2022 and then skyrocketed by 7695.27% in 2025.
  • Accendra Health's Treasury Shares (Quarter) stood at $4.3 million in 2021, then tumbled by 35.79% to $2.8 million in 2022, then dropped by 28.52% to $2.0 million in 2023, then decreased by 0.76% to $2.0 million in 2024, then skyrocketed by 78.88% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $3.7 million for Q2 2025, and $4.0 million during Q1 2025.